BioSpace News Archive

Amador Bioscience, a global translational sciences and clinical pharmacology CRO, announced today that Dr. Meina Liang has joined the company as Chief Technology Officer.

AbbVie (NYSE: ABBV) today announced that it has submitted applications seeking approvals for upadacitinib (RINVOQ®, 15 mg once daily) to the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for the treatment of adults with active non-radiographic axial spondyloarthritis (nr-axSpA) with objective signs of inflammation who have responded inadequately to nonsteroidal anti-inflammatory drugs (NSAIDs).

Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced that on January 6, 2022 it received written notice from The Nasdaq Stock Market LLC (“Nasdaq”) notifying Odonate that Nasdaq believes that Odonate is a “public shell” pursuant to Listing Rule 5101, and that the continued listing of its securities is no longer warranted.

Christina Brennan, MD, MBA, vice president of clinical research at Northwell Health’s Feinstein Institutes for Medical Research, has been elected by members of the Association of Clinical Research Professionals to serve on its Board of Trustees for a second term.

VeriSIM Life www.verisimlife.com, an artificial intelligence-driven bio-pharma technology company with a mission to advance human health by accelerating drug development, today announced its founder and CEO, Jo Varshney, DVM, PhD, will give a corporate presentation at the virtual Biotech Showcase being held January 10-19, 2022.

Today Stimwave Technologies announced the appointment of Chris Valois as its Chief Marketing and Strategy Officer, effective January 1, 2022.

First Wave BioPharma, Inc., today announced that it has further adjourned its Annual Meeting of Stockholders (the “Annual Meeting”) in order to provide stockholders additional time within which to vote on all proposals, including Proposal 2.

Adjuvance Technologies Inc., a privately-held clinical-stage biopharmaceutical company developing next generation saponin adjuvants and vaccines for infectious disease and immuno-oncology, today announced the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 10,906,926.

Genesis MedTech Group (Genesis or Group) has appointed Dr. Eitan Konstantino (Eitan) as CTO of Vascular Interventions to propel Genesis’ technology innovation within the neurovascular, cardiovascular and peripheral vascular spaces.

Help at Home, a leading national provider of in-home, person-centered care, announced today that Chris Hocevar, Chief Executive Officer, and Ryan McGroarty, Chief Financial Officer, are scheduled to participate in the 40th Annual J.P. Morgan 2022 Health Care Conference on Tuesday, Jan. 11, 2022, at 1:30 p.m. Eastern Time .